Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D., ...
hoptownchronicle3h
Ky lawmaker behind bill limiting blood donations from COVID-vaccinated people says it was an error
The bill's sponsor said that restriction was “an error,” and that she intends to change it if it were to move forward in the ...
openaccessgovernment12h
Predicting cancer risk with computational biology
Andrew Teschendorff, Professor at the Chinese Academy of Sciences, is developing computational systems-biological tools to ...
mycharisma4h
5 Alarming End Times Technologies That Signal a Dangerous Future
“Successful self-replication under no human assistance is the essential step for AI to outsmart [humans], and is an early ...
eLife8h
Neuronal Detection Triggers Systemic Digestive Shutdown in Response to Adverse Food Sources
Southwest United Graduate School, Yunnan Key Laboratory of Cell Metabolism and Diseases, State Key Laboratory of Conservation and Utilization of Bio-resources in Yunnan Center for Life Sciences, ...